转录因子-宽关联研究,以确定在阿尔茨海默病中的功能性SNP
Jessica Dunn1, Cedric Moore1, Nam-Shik Kim2
1Department of Pharmacology, Johns Hopkins University, Baltimore, Maryland 21205.
概括
这项研究引入了转录因子广泛关联研究 (TF-WAS) 来解释与阿尔茨海默病 (AD) 的遗传联系. TF-WAS确定了特定的转录因子相互作用,为复杂疾病提供了新的治疗点.
科学领域:
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,具有重大的全球健康影响.
- 全基因组关联研究 (GWAS) 已经确定了与AD相关的遗传变异,但它们的功能解释仍然具有挑战性.
- 将遗传发现转化为AD等复杂疾病的临床应用,需要新的分析方法.
研究的目的:
- 开发和验证一种新的方法,即转录因子广泛关联研究 (TF-WAS),用于解释复杂疾病中的遗传关联.
- 确定功能单核酸多态 (SNP) 和它们与与阿尔茨海默病相关的转录因子 (TF) 的相互作用.
- 发现AD和其他复杂遗传疾病的分子机制和潜在的治疗点.
主要方法:
- 整合GWAS,表达量性特征位点 (eQTL) 和转录组数据来选择功能性AD相关的SNP.
- 人类转录因子 (TF) 微阵列的应用,以确定异位基因特异性TF相互作用.
- 在工程细胞模型中使用电泳运动转移试验 (EMSA),光酶试验和染色体免疫沉 (ChIP) 验证关键的TF-SNP相互作用.
主要成果:
- 在非编码区域中识别了30个假定功能性的AD SNP.
- 发现了90个基因基因特异性TF相互作用,涉及53个独特的TF.
- 与SMAD4的特定相互作用得到了验证,证明了TF-WAS方法的有效性.
结论:
- TF-WAS提供了一个强大的框架,用于剖析复杂疾病中遗传变异的功能后果.
- 鉴定的TF相互作用为阿尔茨海默病的分子病理学提供了洞察力.
- 这种方法可以加速发现神经退行性和其他复杂疾病的新型治疗点.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.8K
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
12.9K
相关概念视频
01:11Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
01:05Single Nucleotide Polymorphisms-SNPs
14.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.0K
02:26Comparing Copy Number Variations and SNPs
17.2K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.2K
01:26Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447